Major Depressive Disorder - Study 1
Study Name: DEPRESSION
Clinics: Blackpool, Liverpool and Manchester
Therapy Area: Depression
Gender and Age: Male and Female aged 18 and over
MAC Clinical Research is currently conducting a clinical trial to test an investigational drug for depression. Despite the availability of numerous methods of medical and psychological treatments, fewer than 50% of all patients with depression show full recovery with optimised treatment.
This trial will test the effect of pimavanserin (the investigational study drug) compared to placebo (inactive pill) on symptoms of depression in patients who are taking an antidepressant that hasn’t fully helped. The study drug or placebo is taken along with the current antidepressant and is taken orally as two tablets once a day.
There will be 8 visits to one of our clinics and 1 phone call from a study physician over a period of 13 weeks. There is no certainty that you will receive any medical benefit from a study physician over a period of 13 weeks. There is no certainty that you will receive any medical benefit from taking part in this study.
Reimbursement: Up to £725
Key Inclusion Criteria*
Male or female aged 18+
Diagnosis of depression
Currently taking a stable dosage of eligible SSRI/SNRI
Key Exclusion Criteria*
Unstable health condition
History of epilepsy
Eligible patients will receive a comprehensive health screen and study participation will be in collaboration with the patient’s treating physician.